Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis.

Atzmony L, Hodak E, Leshem YA, Rosenbaum O, Gdalevich M, Anhalt GJ, Mimouni D.

J Am Acad Dermatol. 2015 Aug;73(2):264-71. doi: 10.1016/j.jaad.2015.04.038. Epub 2015 Jun 16. Review.

PMID:
26088689
2.

Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice.

Culton DA, McCray SK, Park M, Roberts JC, Li N, Zedek DC, Anhalt GJ, Cowley DO, Liu Z, Diaz LA.

J Invest Dermatol. 2015 Jun;135(6):1590-1597. doi: 10.1038/jid.2015.54. Epub 2015 Feb 19.

3.

Pemphigus vulgaris autoantibody profiling by proteomic technique.

Kalantari-Dehaghi M, Anhalt GJ, Camilleri MJ, Chernyavsky AI, Chun S, Felgner PL, Jasinskas A, Leiferman KM, Liang L, Marchenko S, Nakajima-Sasaki R, Pittelkow MR, Zone JJ, Grando SA.

PLoS One. 2013;8(3):e57587. doi: 10.1371/journal.pone.0057587. Epub 2013 Mar 7.

4.

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients.

Leshem YA, Hodak E, David M, Anhalt GJ, Mimouni D.

J Am Acad Dermatol. 2013 Mar;68(3):404-11. doi: 10.1016/j.jaad.2012.08.010. Epub 2012 Oct 6.

PMID:
23044076
5.

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.

Mimouni D, Blank M, Payne AS, Anhalt GJ, Avivi C, Barshack I, David M, Shoenfeld Y.

Clin Exp Immunol. 2010 Dec;162(3):543-9. doi: 10.1111/j.1365-2249.2010.04265.x. Epub 2010 Oct 21.

6.

Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.

Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ.

J Invest Dermatol. 2010 Aug;130(8):2041-8. doi: 10.1038/jid.2010.91. Epub 2010 Apr 22.

7.

Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.

Thorne JE, Woreta FA, Jabs DA, Anhalt GJ.

Ophthalmology. 2008 Dec;115(12):2146-2152.e1. doi: 10.1016/j.ophtha.2008.08.002. Epub 2008 Oct 18.

PMID:
18930554
8.

Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.

Hosler GA, LiƩgeois N, Anhalt GJ, Moresi JM.

J Cutan Pathol. 2008 Nov;35(11):1063-7. doi: 10.1111/j.1600-0560.2007.00931.x. Epub 2008 Jun 9.

PMID:
18544066
9.

Rituximab therapy in severe juvenile pemphigus vulgaris.

Mamelak AJ, Eid MP, Cohen BA, Anhalt GJ.

Cutis. 2007 Oct;80(4):335-40.

PMID:
18038698
10.

Treatment of pyoderma gangrenosum with intravenous immunoglobulin.

Cummins DL, Anhalt GJ, Monahan T, Meyerle JH.

Br J Dermatol. 2007 Dec;157(6):1235-9. Epub 2007 Oct 4. Review.

PMID:
17916196
11.

Adalimumab therapy for recalcitrant pyoderma gangrenosum.

Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH.

J Burns Wounds. 2006 Nov 20;5:e8.

12.

Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.

Cummins DL, Mimouni D, Tzu J, Owens N, Anhalt GJ, Meyerle JH.

J Am Acad Dermatol. 2007 Jan;56(1):153-9. Epub 2006 Sep 14.

PMID:
17097371
13.

Bullous pemphigoid in a patient with systemic sclerosis (scleroderma).

Sherber NS, Wigley FM, Anhalt GJ.

J Rheumatol. 2006 Oct;33(10):2098. No abstract available.

PMID:
17014027
14.

Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid.

Thorne JE, Anhalt GJ, Jabs DA, de la Cruz Z, Green WR.

Ophthalmology. 2006 Sep;113(9):1651-6. Epub 2006 Jul 7.

PMID:
16828515
15.

Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption.

Oliva-Hemker M, Berkenblit GV, Anhalt GJ, Yardley JH.

J Clin Endocrinol Metab. 2006 Aug;91(8):2833-8. Epub 2006 May 9.

PMID:
16684833
16.

Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent.

Tran MM, Anhalt GJ, Barrett T, Cohen BA.

J Am Acad Dermatol. 2006 Apr;54(4):734-6. No abstract available.

PMID:
16546607
17.

Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.

Mimouni D, Blank M, Ashkenazi L, Milner Y, Frusic-Zlotkin M, Anhalt GJ, David M, Shoenfeld Y.

Clin Exp Immunol. 2005 Dec;142(3):426-32.

18.

Mucous membrane pemphigoid of the vulva.

Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ.

Obstet Gynecol. 2005 May;105(5 Pt 2):1188-90.

PMID:
15863576
19.

Paraneoplastic pemphigus in a dog with splenic sarcoma.

Elmore SA, Basseches J, Anhalt GJ, Cullen JM, Olivry T.

Vet Pathol. 2005 Jan;42(1):88-91.

PMID:
15657279
20.

Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.

Mimouni D, Foedinger D, Kouba DJ, Orlow SJ, Rappersberger K, Sciubba JJ, Nikolskaia OV, Cohen BA, Anhalt GJ, Nousari CH.

J Am Acad Dermatol. 2004 Jul;51(1):62-7.

PMID:
15243525

Supplemental Content

Loading ...
Support Center